Scaling new heights in the fight against heart disease
Founded by leading cardiovascular scientists, our team has the tenacity to pursue our ultimate peak – changing the treatment paradigm for heart disease, and in doing so improving and extending the lives of millions of individuals and families fighting this debilitating disease.
We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease.
We are revolutionizing the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.
LATEST NEWS
Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference
Heart Failure 2022 Presentation Includes Preclinical Data Supporting TN-301 Effect in HFpEF Models TN-301 IND Submission on Track for Second Half of 2022 SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 20, 2022-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to
Read MoreTenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
TN-201 Received Orphan Medicinal Product Designation from the European Commission Preclinical TN-401 Data Presented at Heart Rhythm 2022 SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 11, 2022-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover,
Read MoreTenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting
ASGCT Presentations Include Preclinical Data for TN-401 PKP2 and DWORF Gene Therapy Programs and AAV Capsid Engineering Innovations SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 3, 2022-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop
Read MoreJOIN OUR TEAM
Are you ambitious, driven, energized by scientific innovation and committed to making a difference for patients suffering from heart disease? Do you value a culture grounded in science and collaboration? Our team combines deep biological insights, sophisticated drug development technologies and a boundless determination to change the future for the millions of people affected by heart disease.
